
GC26027
V-0219
Also known as 4-[[1-[[3-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]methyl]piperidin-3-yl]methyl]morpholine
V-0219 is an orally active, positive allosteric modulator (PAM) of the glucagon-like peptide-1 receptor (GLP-1R), can be used for obesity-associated diabetes research
ChemicalCAS878453-71-5MW410.43FormulaC20H25F3N4O2
- CAS number
- 878453-71-5
- Molecular weight
- 410.43
- Formula
- C20H25F3N4O2
- Solubility
- DMSO: 97 mg/mL (236·34 mM);Water: 97 mg/mL (236·34 mM);Ethanol: 97 mg/mL (236·34 mM)
- InChIKey
- VFQGZIAZHIRPPQ-UHFFFAOYSA-N
- Catalogue number
- GC26027
- Brand
- GLPBIO
Computed properties PubChem CID 6486002 · XLogP 3 · TPSA 54.6 Ų · H-bond donors 0
- XLogP
- 3
- TPSA
- 54.6 Ų
- H-bond donors
- 0
- H-bond acceptors
- 9
- Rotatable bonds
- 5
- Heavy atoms
- 29
SMILES C1CC(CN(C1)CC2=NC(=NO2)C3=CC=C(C=C3)C(F)(F)F)CN4CCOCC4
Computed descriptors from PubChem (CID 6486002), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il